Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitochondria01:37

Mitochondria

19.3K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
19.3K
Glaucoma: Overview01:25

Glaucoma: Overview

1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

901
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
901

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Halofluorocarbon Regulation of Li Metal/Li<sub>6</sub>PS<sub>5</sub>Cl Interfaces Through a C<sub>6</sub>F<sub>13</sub>I-Derived LiF/LiI-Rich Interphase.

Chemphyschem : a European journal of chemical physics and physical chemistry·2026
Same author

Evaluating the Long-term Success and Safety of Canaloplasty in Glaucoma Patients.

Klinische Monatsblatter fur Augenheilkunde·2026
Same author

Clinical Outcomes of Combined Pars Plana Vitrectomy and PAUL Glaucoma Implant.

Journal of glaucoma·2026
Same author

Malnutrition as a Risk Factor for Cerebral and Glaucomatous Neurodegeneration - Mechanisms and Therapeutic Strategies.

Klinische Monatsblatter fur Augenheilkunde·2026
Same author

Ocular Adverse Events Associated With Antidepressants: A Large-Scale Data Analysis From the FAERS Database.

CNS neuroscience & therapeutics·2026
Same author

A Systematic and Narrative Review of Safety and Complications in Minimally Invasive Glaucoma Surgery (MIGS) Between 2014-2024 [Response to Letter].

Clinical ophthalmology (Auckland, N.Z.)·2026

Related Experiment Video

Updated: Dec 30, 2025

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
12:48

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

11.0K

Mitochondrial Markers in Aging and Primary Open-Angle Glaucoma.

Hanhan Liu1, Karl Mercieca2,3, Verena Prokosch1

  • 1Experimental Ophthalmology, Department of Ophthalmology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Journal of Glaucoma
|January 25, 2020
PubMed
Summary

This review explores mitochondrial markers in glaucoma and discusses therapies targeting mitochondrial function for better patient outcomes.

More Related Videos

Determination of Mitochondrial Respiration and Glycolysis in Ex Vivo Retinal Tissue Samples
08:45

Determination of Mitochondrial Respiration and Glycolysis in Ex Vivo Retinal Tissue Samples

Published on: August 4, 2021

4.7K
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.1K

Related Experiment Videos

Last Updated: Dec 30, 2025

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
12:48

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

11.0K
Determination of Mitochondrial Respiration and Glycolysis in Ex Vivo Retinal Tissue Samples
08:45

Determination of Mitochondrial Respiration and Glycolysis in Ex Vivo Retinal Tissue Samples

Published on: August 4, 2021

4.7K
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.1K

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Neuroscience

Background:

  • Glaucoma is a leading cause of irreversible blindness.
  • Mitochondrial dysfunction is increasingly recognized as a key factor in glaucoma pathogenesis.
  • Identifying reliable mitochondrial markers is crucial for diagnosis and treatment.

Purpose of the Study:

  • To review recent advancements in understanding mitochondrial dysfunction in glaucoma.
  • To discuss novel therapeutic strategies aimed at modulating mitochondrial function.
  • To highlight the potential of targeting mitochondria for improved glaucoma management.

Main Methods:

  • Comprehensive literature search of recent studies on glaucoma and mitochondria.
  • Analysis of research on mitochondrial markers and their association with glaucoma.
  • Review of emerging therapeutic interventions targeting mitochondrial pathways.

Main Results:

  • Mitochondrial dysfunction contributes significantly to retinal ganglion cell (RGC) death in glaucoma.
  • Specific mitochondrial proteins and metabolites show altered levels in glaucoma patients.
  • Therapies enhancing mitochondrial function demonstrate neuroprotective effects in preclinical models.

Conclusions:

  • Mitochondrial markers offer potential for early diagnosis and prognosis of glaucoma.
  • Targeting mitochondrial dysfunction presents a promising therapeutic avenue for glaucoma.
  • Further research is needed to translate these findings into clinical practice.